N-(2-(氨基甲基)苯基)-1-苄基哌啶-4-胺 | 79098-90-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: N-(2-(氨基甲基)苯基)-1-苄基哌啶-4-胺
• 英文名称: 1-benzyl-4-[N-(o-aminomethylphenyl)-amino]-piperidine
• 英文别名: 1-benzyl-4-<2-(aminomethyl)anilino>piperidine；1-benzyl-4-(2-aminomethylphenyl)aminopiperidine；1-Benzyl-4-[N-(o-aminomethylphenyl)-amino]piperidine；1-benzyl-4-((2-aminomethyl)phenylamino)piperidine；N-[2-(Aminomethyl)phenyl]-1-benzylpiperidin-4-amine
• CAS: 79098-90-1
• 化学式: C₁₉H₂₅N₃
• 分子量: 295.428
• InChiKey: UUJYNYPLIGRUQA-UHFFFAOYSA-N

物化性质

• 沸点：
  460.2±45.0 °C(Predicted)
• 密度：
  1.132±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  41.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(2-(氨基甲基)苯基)-1-苄基哌啶-4-胺 在 吡啶 、 磺酰胺 作用下， 以67%的产率得到1-benzyl-4-(3,4-dihydro-2,2-dioxo-1H-2,1,3-benzothiadiazin-1-yl)piperidine
  参考文献：
  名称：

  1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptor

  摘要：

  A series of 1,3-dihydro-2,1,3-benzothiadiazol-2,2-diones (1) and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones (II) were prepared. While the five-member ring series (I) did not show good affinity for opioid receptors, the six-member ring series (II) exhibited extremely high affinity and selectivity for the NOP receptor and showed full agonist activity, as determined by stimulation of GTPgamma[S-35] binding. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.08.001
• 作为产物：
  描述：

  2-[[1-(phenylmethyl)-4-piperidinyl]amino]-benzamide 在 lithium aluminium tetrahydride 作用下， 以 1,4-二氧六环 为溶剂， 生成 N-(2-(氨基甲基)苯基)-1-苄基哌啶-4-胺
  参考文献：
  名称：

  Rapid access towards follow-up NOP receptor agonists using a knowledge based approach

  摘要：

  A knowledge based approach has been adopted to identify novel NOP receptor agonists with simplified hydrophobes. Substitution of the benzimidazol-2-one piperidine motif with a range of hydrophobic groups and pharmacophore guided bio-isosteric replacement of the benzimidazol-2-one moiety was explored. Compound 51 was found to be a high affinity, potent NOP receptor agonist with reduced affinity for the hERG channel. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.09.028

文献信息

• Synthesis and pharmacological evaluation of piperidine derivatives with various heterocyclic rings at the 4-position.
  作者：HARUKI TAKAI、HIROYUKI OBASE、NOBUHIRO NAKAMIZO、MASAYUKI TERANISHI、KAZUHIRO KUBO、KATSUICHI SHUTO、TAMOTSU HASHIMOTO

  DOI：10.1248/cpb.33.1104

  日期：——

  A series of piperidine derivatives with various heterocyclic rings at the 4-position was prepared and tested for antihypertensive activity and other biological activities. The antihypertensive effects of the present compounds in the spontaneous hypertensive rat were less potent than those of previously reported compounds. However, among the compounds tested for antiulcer activity and antiinflammatory activity, some exhibited interesting properties.

  制备并在4-位具有各种杂环的一类哌啶衍生物，进行了抗高血压活性及其他生物活性的测试。本研究所合成的化合物在自发性高血压大鼠中的抗高血压效果不及先前报道的化合物。然而，在用于抗溃疡活性和抗炎活性测试的化合物中，一些展现出了有趣的特性。
• Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin
  申请人：Merck & Co., Inc.

  公开号：US05665719A1

  公开（公告）日：1997-09-09

  Compounds of the formula ##STR1## X is --O--, --NH-- and --NR.sup.8 --; Y is --CH.sub.2 --, --CHR.sup.8 -- and --C(R.sup.8).sub.2 --; R.sup.1 is camphor-10-yl, C.sub.1-5 alkoxyl, styryl, hydroxystyryl, furyl, unsubstituted or substituted thienyl, naphthyl, indolyl, tetrahydronaphthyl, unsubstituted, mono- or di-substituted pyridyl, pyrazinyl, unsubstituted or substituted cyclohexyl where the substituent is R.sup.4, and unsubstituted or substituted phenyl where the substituents on phenyl are R.sup.5, R.sup.6 and R.sup.7 ; R.sup.2 is hydrogen, C.sub.1-5 alkoxy, C.sub.1-5 alkyl, amino, C.sub.1-5 alkylcarbonylamino, nitro or halogen; R.sup.3 is hydrogen, C.sub.1-5 alkoxycarbonyl, cyano or carbamoyl; R.sup.4 is one to two of hydrogen, oxo, hydroxy, C.sub.1-5 alkoxy, C.sub.1-5 alkoxycarbonylamino-C.sub.1-5 alkyl and amino-C.sub.1-5 alkyl; R.sup.5, R.sup.6 are each independently selected from hydrogen, halogen, C.sub.1-5 alkyl, hydroxyl and C.sub.1-5 alkoxy; R.sup.7 is ##STR2## W is CO or SO.sub.2 ; and m is an integer from 0 to 1. Such compounds as useful as oxytocin and vasopressin receptor antagonists.

  该公式化合物的翻译如下： X为--O--，--NH--和--NR.sup.8--；Y为--CH.sub.2--，--CHR.sup.8--和--C(R.sup.8).sub.2--；R.sup.1为樟脑-10-基，C.sub.1-5烷氧基，苯乙烯基，羟基苯乙烯基，呋喃基，未取代或取代噻吩基，萘基，吲哚基，四氢萘基，未取代，单取代或双取代吡啶基，吡嗪基，未取代或取代的环己基，其中取代基为R.sup.4，以及未取代或取代的苯基，苯基上的取代基为R.sup.5，R.sup.6和R.sup.7；R.sup.2为氢，C.sub.1-5烷氧基，C.sub.1-5烷基，氨基，C.sub.1-5烷基羰基氨基，硝基或卤素；R.sup.3为氢，C.sub.1-5烷氧羰基，氰基或氨基甲酰基；R.sup.4为氢，氧代，羟基，C.sub.1-5烷氧基，C.sub.1-5烷氧羰基氨基-C.sub.1-5烷基和氨基-C.sub.1-5烷基中的一种或两种；R.sup.5，R.sup.6分别独立选择自氢，卤素，C.sub.1-5烷基，羟基和C.sub.1-5烷氧基；R.sup.7为##STR2## W为CO或SO.sub.2；m为0到1的整数。这些化合物可用作催产素和抗利尿激素受体拮抗剂。
• Piperidine derivatives
  申请人：Kyowa Hakko Kogyo Co., Ltd.

  公开号：US04344945A1

  公开（公告）日：1982-08-17

  New piperidine derivatives which have a useful pharmacological activity such as hypotensive activity are prepared.

  制备了具有有用药理活性（如降压活性）的新哌啶衍生物。
• Synthesis of 1- and 3-(1-substituted 4-piperidinyl)-1,2,3,4-tetrahydro-2-oxoquinazolines as potential antihypertensive agents.
  作者：HARUKI TAKAI、HIROYUKI OBASE、NOBUHIRO NAKAMIZO、MASAYUKI TERANISHI、KAZUHIRO KUBO、KATSUICHI SHUTO、YUTAKA KASUYA、KOKI SHIGENOBU、MAKIKO HASHIKAMI、NAOKO KARASHIMA

  DOI：10.1248/cpb.33.1116

  日期：——

  A series of 1-and 3-(1-substituted 4-piperidinyl)-1, 2, 3, 4-tetrahydro-2-oxoquinazolines were synthesized and tested for antihypertensive activity. Among the compounds tested, 1-(2-hydroxy-2-phenethyl)-4-(1, 2, 3, 4-tetrahydro-2-oxo-3-quinazolinyl) piperidine derivatives were generally the most effective in lowering blood pressure in the spontaneous hypertensive rat model. Of these, 1-[2-(4-chlorophenyl)-2-hydroxyethyl]-4-(1, 2, 3, 4-tetrahydro-2-oxo-3-quinazolinyl) piperidine (26) (KF5908) seemed the most promising.

  合成了一系列1-和3-(1-取代4-哌啶基)-1, 2, 3, 4-四氢-2-酮喹唑啉，并测试了它们的抗高血压活性。在测试的化合物中，1-(2-羟基-2-苯乙基)-4-(1, 2, 3, 4-四氢-2-酮-3-喹唑啉基)哌啶衍生物通常在自发性高血压大鼠模型中降低血压的效果最佳。其中，1-[2-(4-氯苯基)-2-羟基乙基]-4-(1, 2, 3, 4-四氢-2-酮-3-喹唑啉基)哌啶（26）（KF5908）似乎最具前景。
• Piperidine derivatives and pharmaceutical compositions containing same
  申请人：Kyowa Hakko Kogyo Co., Ltd.

  公开号：US04344948A1

  公开（公告）日：1982-08-17

  A new piperidine derivative represented by the formula: ##STR1## wherein X is oxygen, sulfur, carbonyl, hydroxymethylene or methylene; R is straight-chain alkylene having 1-4 carbon atoms with or without lower alkyl substituent(s); m and n are 0 or 1, and are different from each other (i.e., both m and n are not 0 or 1); and (D).sub.m', R.sup.1 and (R.sup.2)n' are usually used as substituents, has a hypotensive activity.

  一种新的哌啶衍生物，其化学式为：##STR1## 其中X为氧、硫、酰基、羟甲基或亚甲基；R为直链烷基，含有1-4个碳原子，可以带有或不带有较低的烷基取代基；m和n为0或1，并且彼此不同（即，m和n均不为0或1）；(D)。m'、R1和(R2)n'通常用作取代基，具有降压活性。